The errors were due to misclassification of the 2 intervention periods of 1 of the 16 ICUs, discovered in the course of rechecking the code in conjunction with an individual patient data meta-analysis. We have corrected the errors and confirmed that there are no other errors after reviewing our original analysis and findings. The correction, though, has changed some of the secondary end points of the study: the previously reported absence of statistically significant differences in day 28 mortality, ICU mortality, hospital mortality, length of stay, and rate of candidemia are now statistically significant, favoring SDD over SOD. Thus, we have requested that the original article be retracted and replaced.
As a result of the mislabeling of interventions in 1 ICU, the flow diagram and Tables 1, 3 , 4, and 5 have changed. For day 28 mortality the correct data are 25.7% during SOD and 23.8% during SDD with a corresponding adjusted odds ratio (OR) of 0.850 (95% CI, 0.774-0.933). For ICU mortality the correct data are 20.0% during SOD and 18.4% during SDD with a corresponding adjusted OR of 0.842 (95% CI, 0.759-0.933). For hospital mortality the correct data are 28.2% during SOD and 26.3% during SDD with a corresponding adjusted OR of 0.857 (95% CI, 0.783-0.938). For length of ICU stay the correct data are median of 6 days (IQR, 4-10 days) during SOD and 6 days (IQR, 4-11 days) during SDD (OR, 1.056 [95% CI, 1.014-1.100]). For candidemia the correct data are 1.0% during SOD and 0.5% during SDD with a corresponding OR of 0.47 (95% CI, 0.30-0.75).
The corrections for these errors indicate that the previously reported absence of statistically significant differences in secondary outcomes has been changed and the article now concludes: "Unit-wide application of SDD and SOD was associated with low levels of antibiotic resistance. Compared with SOD, SDD was associated with lower mortality, reduced length of stay, lower rates of ICU-acquired bacteremia and candidemia, and lower prevalence of rectal carriage of antibioticresistant gram-negative bacteria, but a more pronounced gradual increase in aminoglycoside-resistant gram-negative bacteria."
We deeply regret this error as well as the confusion caused to JAMA, readers, and potentially to physicians. The original article has been corrected. An additional online supplement has been added that includes a version of the original article with the errors highlighted and a version of the replacement article with the corrections highlighted.
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